Kevin Young, EVP, Commercial Operations at GILEAD SCIENCES INC (GILD), sold 30,000 shares at $46.85 ($1.4M) on 2008-01-07, disclosed to the SEC on 2008-01-09.
Scheduled sale ($1.4M) by EVP, Commercial Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.70 | 3,000 | $140K | 10.0% |
| 2 | $46.74 | 3,000 | $140K | 10.0% |
| 3 | $46.75 | 5,000 | $234K | 16.7% |
| 4 | $46.77 | 2,000 | $94K | 6.7% |
| 5 | $46.80 | 10,000 | $468K | 33.3% |
| 6 | $46.81 | 2,000 |
| $94K |
| 6.7% |
| 7 | $46.85 | 5,000 | $234K | 16.7% |
| Total | $46.78 avg | 30,000 | $1.4M | 100% |
| Filing → |
| GILD | SELL | 2013-12-24 | $5.6M | — | Filing → |
| GILD | SELL | 2013-11-25 | $5.6M | — | Filing → |
| GILD | SELL | 2013-10-25 | $5.1M | — | Filing → |